Steven C. Salop argues that as part of any remedy outcome from the Google Search case, Google cannot be permitted to enter agreements with...

Three antitrust experts review the trends and cases that defined European antitrust and competition in 2024. Apple’s unfair trading conditions and the Digital Markets Act Alessia...

Three antitrust experts review the trends and cases that defined United States antitrust in 2024.

The ongoing debates about the EU’s competition policy have predominantly focused on Western Europe, overlooking the dynamic growth and unique challenges of Central and Eastern Europe, writes Maciej Bernatt and Kati Cseres. This oversight risks deepening economic disparities and undermining the EU’s goals of unity, democracy, and innovation-driven growth.

New research from Christopher Stewart, John Kepler, and Charles McClure shows that thousands of large mergers and acquisitions bypass antitrust review because current regulatory thresholds ignore intangible assets like intellectual property and customer data. These unreported deals, particularly in tech and pharma sectors, show signs of being more anticompetitive - with higher premiums paid, increased market power for acquirers, and evidence of "killer acquisitions" in pharmaceuticals.

Despite fundamental changes in the real economy, and strides in the regulation of privacy, data, and digital markets, antitrust practice and discourse in Europe are still conducted in “safe spaces” where the antitrust community resists change and remains attached to neoliberal approaches and efficiency goals. But the Trump Administration will not just signify a wholesale return to pre-NeoBrandeisian times (as many in Europe hope): indeed Europeans hiding in their “safe spaces” may well be surprised, writes Cristina Caffarra.